Literature DB >> 34162958

Multiparametric characterization of white matter alterations in early stage Huntington disease.

Isaac M Adanyeguh1, Francesca Branzoli1,2, Cécile Delorme3, Aurélie Méneret1,3, Marie-Lorraine Monin1, Marie-Pierre Luton1, Alexandra Durr1, Emanoel Sabidussi1, Fanny Mochel4,5.   

Abstract

Huntington's disease (HD) is a monogenic, fully penetrant neurodegenerative disorder. Widespread white matter damage affects the brain of patients with HD at very early stages of the disease. Fixel-based analysis (FBA) is a novel method to investigate the contribution of individual crossing fibers to the white matter damage and to detect possible alterations in both fiber density and fiber-bundle morphology. Diffusion-weighted magnetic resonance spectroscopy (DW-MRS), on the other hand, quantifies the motion of brain metabolites in vivo, thus enabling the investigation of microstructural alteration of specific cell populations. The aim of this study was to identify novel specific microstructural imaging markers of white matter degeneration in HD, by combining FBA and DW-MRS. Twenty patients at an early stage of HD and 20 healthy controls were recruited in a monocentric study. Using diffusion imaging we observed alterations to the brain microstructure and their morphology in patients with HD. Furthermore, FBA revealed specific fiber populations that were affected by the disease. Moreover, the mean diffusivity of the intra-axonal metabolite N-acetylaspartate, co-measured with N-acetylaspartylglutamate (tNAA), was significantly reduced in the corpus callosum of patients compared to controls. FBA and DW-MRS of tNAA provided more specific information about the biological mechanisms underlying HD and showed promise for early investigation of white matter degeneration in HD.

Entities:  

Year:  2021        PMID: 34162958     DOI: 10.1038/s41598-021-92532-1

Source DB:  PubMed          Journal:  Sci Rep        ISSN: 2045-2322            Impact factor:   4.379


  22 in total

1.  Potential endpoints for clinical trials in premanifest and early Huntington's disease in the TRACK-HD study: analysis of 24 month observational data.

Authors:  Sarah J Tabrizi; Ralf Reilmann; Raymund A C Roos; Alexandra Durr; Blair Leavitt; Gail Owen; Rebecca Jones; Hans Johnson; David Craufurd; Stephen L Hicks; Christopher Kennard; Bernhard Landwehrmeyer; Julie C Stout; Beth Borowsky; Rachael I Scahill; Chris Frost; Douglas R Langbehn
Journal:  Lancet Neurol       Date:  2011-12-02       Impact factor: 44.182

2.  Longitudinal Diffusion Tensor Imaging Shows Progressive Changes in White Matter in Huntington's Disease.

Authors:  Sarah Gregory; James H Cole; Ruth E Farmer; Elin M Rees; Raymund A C Roos; Reiner Sprengelmeyer; Alexandra Durr; Bernhard Landwehrmeyer; Hui Zhang; Rachael I Scahill; Sarah J Tabrizi; Chris Frost; Nicola Z Hobbs
Journal:  J Huntingtons Dis       Date:  2015

3.  White matter connections reflect changes in voluntary-guided saccades in pre-symptomatic Huntington's disease.

Authors:  Stefan Klöppel; Bogdan Draganski; Charlotte V Golding; Carlton Chu; Zoltan Nagy; Philip A Cook; Stephen L Hicks; Christopher Kennard; Daniel C Alexander; Geoff J M Parker; Sarah J Tabrizi; Richard S J Frackowiak
Journal:  Brain       Date:  2007-12-03       Impact factor: 13.501

4.  White matter integrity, fiber count, and other fallacies: the do's and don'ts of diffusion MRI.

Authors:  Derek K Jones; Thomas R Knösche; Robert Turner
Journal:  Neuroimage       Date:  2012-07-23       Impact factor: 6.556

5.  Longitudinal change in white matter microstructure in Huntington's disease: The IMAGE-HD study.

Authors:  Govinda R Poudel; Julie C Stout; Juan F Domínguez D; Andrew Churchyard; Phyllis Chua; Gary F Egan; Nellie Georgiou-Karistianis
Journal:  Neurobiol Dis       Date:  2014-12-12       Impact factor: 5.996

Review 6.  Structural MRI in Huntington's disease and recommendations for its potential use in clinical trials.

Authors:  Nellie Georgiou-Karistianis; Rachael Scahill; Sarah J Tabrizi; Ferdinando Squitieri; Elizabeth Aylward
Journal:  Neurosci Biobehav Rev       Date:  2013-01-29       Impact factor: 8.989

7.  In vivo evidence for the selective subcortical degeneration in Huntington's disease.

Authors:  Gwenaëlle Douaud; Timothy E Behrens; Cyril Poupon; Yann Cointepas; Saâd Jbabdi; Véronique Gaura; Narly Golestani; Pierre Krystkowiak; Christophe Verny; Philippe Damier; Anne-Catherine Bachoud-Lévi; Philippe Hantraye; Philippe Remy
Journal:  Neuroimage       Date:  2009-03-28       Impact factor: 6.556

8.  Diffusion tensor imaging of brain white matter in Huntington gene mutation individuals.

Authors:  Roberta Arb Saba; James H Yared; Thomas M Doring; Med Phys; Vanderci Borges; Henrique Ballalai Ferraz
Journal:  Arq Neuropsiquiatr       Date:  2017-08       Impact factor: 1.420

9.  Investigating white matter fibre density and morphology using fixel-based analysis.

Authors:  David A Raffelt; J-Donald Tournier; Robert E Smith; David N Vaughan; Graeme Jackson; Gerard R Ridgway; Alan Connelly
Journal:  Neuroimage       Date:  2016-09-14       Impact factor: 6.556

10.  Complex spatial and temporally defined myelin and axonal degeneration in Huntington disease.

Authors:  H D Rosas; P Wilkens; D H Salat; N D Mercaldo; M Vangel; A Y Yendiki; S M Hersch
Journal:  Neuroimage Clin       Date:  2018-02-19       Impact factor: 4.881

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.